Increased fibrinolytic activity occurs as a shift in the balance between pro-fibrinolytic (t-PA) and anti-fibrinolytic (PAI-1) factors, as characterized by an increase in global fibrinolytic capacity and a reduction of clot lysis time, particularly in patients with liver cirrhosis (11). This evidence concerns the gene SERPINE1 and cirrhosis of liver.